POST FINASTERIDE SYNDROME ( PSF)

and the FOOD and DRUG ADMINISTRATION (FDA)

Use of 5 alpha-reductase inhibitors after the Food and Drug Administration (FDA)

See powerpoint:

 

 

 

Between 1993 and 2020, the iatrogeny has reproduced and aggravated two pathologies

through the manufacture of
5-alpha-reductase for illusory and dangerous prescriptions :

The syndrome of prostate atrophy (1979)

and

The androgenic disease of andropause (1988)